PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.15%
Revenue growth of 9.15% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
5.86%
Gross profit growth of 5.86% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
12.81%
EBIT growth exceeding 1.5x Healthcare median of 2.53%. Joel Greenblatt would examine whether a unique competitive edge supports this outperformance.
12.93%
Operating income growth exceeding 1.5x Healthcare median of 1.36%. Joel Greenblatt would see if unique processes drive exceptional profitability.
-13.39%
Negative net income growth while Healthcare median is 5.08%. Seth Klarman would investigate factors dragging net income down.
-13.40%
Negative EPS growth while Healthcare median is 7.31%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-13.40%
Negative diluted EPS growth while Healthcare median is 7.55%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Dividend cuts while Healthcare median is 0.00%. Seth Klarman would see if others maintain or grow payouts, highlighting a relative weakness.
-2.38%
Negative OCF growth while Healthcare median is -10.52%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
-2.38%
Negative FCF growth while Healthcare median is -8.17%. Seth Klarman would see if others in the industry are still generating positive expansions in free cash.
157.75%
10Y CAGR of 157.75% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
57.39%
5Y CAGR of 57.39% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
27.75%
3Y CAGR of 27.75% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
108.53%
Net income/share CAGR exceeding 1.5x Healthcare median of 2.15% over a decade. Joel Greenblatt might see a standout compounder of earnings.
33.23%
Net income/share CAGR of 33.23% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
-13.11%
Negative 3Y CAGR while Healthcare median is 0.00%. Seth Klarman might see a pressing concern if the rest of the sector is stable or growing.
353.50%
Equity/share CAGR exceeding 1.5x Healthcare median of 16.56% over 10 years. Joel Greenblatt would see if a high ROE underlies this compounding advantage.
90.72%
5Y equity/share CAGR > 1.5x Healthcare median of 4.56%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
41.66%
3Y equity/share CAGR > 1.5x Healthcare median of 3.03%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
9.07%
AR growth of 9.07% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
3.03%
Inventory growth of 3.03% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
3.36%
We expand assets while Healthcare is negative. Peter Lynch sees a possible advantage if expansions align with profitable markets or a recovering cycle.
2.00%
Positive BV/share change while Healthcare median is negative. Peter Lynch finds a strong advantage vs. peers failing to expand equity.
-33.66%
Debt is shrinking while Healthcare median is rising. Seth Klarman might see an advantage if growth remains possible.
No Data
No Data available this quarter, please select a different quarter.
83.99%
SG&A growth of 83.99% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.